Fletcher Aaron G.L. 4

What Happened Fletcher Aaron G.L., listed as a 10% owner of Actuate Therapeutics (ACTU), was granted a derivative award covering 15,000 shares on 2026-05-21. The Form 4 reports an acquisition at $0.00 (total reported value $0), indicating a grant of derivative securities (options/awarded units) rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-05-21; filing date: 2026-05-22 (Form 4 filed the next day — appears timely).
• Security: derivative award covering 15,000 shares; reported price $0.00; reported value $0.
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: options will vest in full on the one‑year anniversary of the grant date.
• Transaction type code: A (grant/award/other acquisition).

Context This filing documents an award of derivative securities (an option-style grant that will vest in one year). Because the insider is a 10% owner, this reflects a change to a large shareholder’s holdings rather than a routine open‑market buy or sale by an officer. The grant itself is an acquisition (not a sale) but does not reflect an immediate cash outlay or stock sale.